Bessemer Trust: No New Encumbrance on Nephrocare Shares
An individual reviews a financial document confirming unencumbered shares in a modern office.
Key Highlights
Bessemer Venture Partners Trust confirms no new encumbrance on Nephrocare Health Services shares for FY26, upholding SEBI transparency norms for investors.
Bessemer Venture Partners Trust Confirms Unencumbered Nephrocare Shares
Bessemer Venture Partners Trust, a significant promoter of Nephrocare Health Services Limited, has officially declared that no new encumbrance was created on the company’s shares during the fiscal year concluding on March 31, 2026. This confirmation is crucial for market participants, as it provides transparency regarding the promoter’s financial position and commitment to the company, influencing investor confidence and market perceptions.
Adherence to SEBI Regulations Ensures Transparency
The declaration was made in strict compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation is designed to ensure robust corporate governance and investor protection by mandating promoters to disclose any pledges or liens on their shares. Such disclosures are vital for maintaining an equitable and informed trading environment, preventing potential market distortions.
By adhering to these stringent regulatory requirements, Bessemer Venture Partners Trust reinforces its commitment to transparent practices. The absence of new encumbrances signals stability in the promoter’s holdings, which can be a positive indicator for shareholders assessing the company’s long-term prospects and the financial health of its key backers.
Disclosure to Major Stock Exchanges
To ensure broad public access and complete transparency, the official declaration was submitted to both the Limited and the of India Limited (NSE). These submissions place the information on public record, making it readily available for all stakeholders, including current and prospective investors, analysts, and regulatory bodies.
The public filing through these prominent stock exchanges underscores the importance of regulatory compliance in India’s financial markets. It allows for immediate dissemination of critical information that can impact investment decisions, ensuring that the market operates on reliable and timely data concerning promoter shareholding patterns.
Formal Signatory and Internal Documentation
The disclosure document bore the signature of Sandiren Ramsamy, who acted on behalf of Apex Group Trustees (Mauritius) as the trustee for Bessemer Venture Partners Trust. This formal endorsement lends credibility and legal weight to the declaration, confirming its official status.
In addition to the external filings, copies of the declaration were also provided to Nephrocare Health Services Limited’s Audit Committee and Company Secretary. This internal distribution ensures that the company’s governance structures are fully informed and that internal records are consistent with external disclosures, maintaining comprehensive oversight and accountability within the organization.